Covered recipient · General Payments record
TIMOTHY JOHN NOWATZKE
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$5,032.05
- Reported across 231 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $1,140.00 | 1 |
| Food and Beverage | $981.73 | 52 |
| Education | $8.45 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $1,332.92 | 7 |
| ABBVIE INC. | $405.62 | 27 |
| Janssen Biotech, Inc. | $105.16 | 5 |
| Dermavant Sciences, Inc. | $66.75 | 4 |
| LEO Pharma Inc. | $43.33 | 2 |
| Regeneron Healthcare Solutions, Inc. | $33.86 | 2 |
| PFIZER INC. | $32.58 | 2 |
| Krystal Biotech Inc | $24.09 | 1 |
| Galderma Laboratories, L.P. | $23.41 | 1 |
| Lilly USA, LLC | $22.72 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $21.98 | 1 |
| GENZYME CORPORATION | $17.76 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (54)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.59 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107747823 | CMS |
| ABBVIE INC. | $6.25 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107747825 | CMS |
| ABBVIE INC. | $12.01 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107747827 | CMS |
| ABBVIE INC. | $16.04 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107747829 | CMS |
| ABBVIE INC. | $14.14 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107747831 | CMS |
| ABBVIE INC. | $21.05 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107747833 | CMS |
| ABBVIE INC. | $21.88 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107747835 | CMS |
| ABBVIE INC. | $8.96 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107747837 | CMS |
| ABBVIE INC. | $4.09 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107747839 | CMS |
| ABBVIE INC. | $24.63 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107747841 | CMS |
| ABBVIE INC. | $16.41 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107747843 | CMS |
| ABBVIE INC. | $16.49 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107747845 | CMS |
| ABBVIE INC. | $4.19 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107747847 | CMS |
| ABBVIE INC. | $8.45 | 06/27/2024 | Education | Undisputed | 01/23/2026 | 1107747849 | CMS |
| ABBVIE INC. | $14.14 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107747851 | CMS |
| ABBVIE INC. | $19.68 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107747853 | CMS |
| ABBVIE INC. | $6.53 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107747855 | CMS |
| ABBVIE INC. | $17.81 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107747857 | CMS |
| ABBVIE INC. | $13.80 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107747859 | CMS |
| ABBVIE INC. | $15.82 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107747861 | CMS |
| ABBVIE INC. | $16.82 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107747863 | CMS |
| ABBVIE INC. | $14.03 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107747865 | CMS |
| ABBVIE INC. | $27.71 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107747867 | CMS |
| ABBVIE INC. | $14.67 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107747869 | CMS |
| ABBVIE INC. | $14.63 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107747871 | CMS |
| ABBVIE INC. | $18.61 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107747873 | CMS |
| ABBVIE INC. | $15.19 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107747875 | CMS |
| Dermavant Sciences, Inc. | $15.20 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128001159 | CMS |
| Dermavant Sciences, Inc. | $16.54 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128001161 | CMS |
| Dermavant Sciences, Inc. | $18.45 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128001163 | CMS |
| Dermavant Sciences, Inc. | $16.56 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128001165 | CMS |
| Galderma Laboratories, L.P. | $23.41 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145380229 | CMS |
| GENZYME CORPORATION | $17.76 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139713956 | CMS |
| Janssen Biotech, Inc. | $17.70 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078788858 | CMS |
| Janssen Biotech, Inc. | $21.46 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078788746 | CMS |
| Janssen Biotech, Inc. | $22.19 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078788576 | CMS |
| Janssen Biotech, Inc. | $22.01 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078788584 | CMS |
| Janssen Biotech, Inc. | $21.80 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078788641 | CMS |
| Krystal Biotech Inc | $24.09 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084811870 | CMS |
| LEO Pharma Inc. | $24.98 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152681809 | CMS |
| LEO Pharma Inc. | $18.35 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152681811 | CMS |
| Lilly USA, LLC | $22.72 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135975564 | CMS |
| Novartis Pharmaceuticals Corporation | $21.98 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087071940 | CMS |
| PFIZER INC. | $13.87 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131137113 | CMS |
| PFIZER INC. | $18.71 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131696569 | CMS |
| Regeneron Healthcare Solutions, Inc. | $19.14 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114350565 | CMS |
| Regeneron Healthcare Solutions, Inc. | $14.72 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114350567 | CMS |
| UCB, Inc. | $1,140.00 | 02/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1143314972 | CMS |
| UCB, Inc. | $114.96 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143314976 | CMS |
| UCB, Inc. | $11.62 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143314981 | CMS |
| UCB, Inc. | $17.51 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143314985 | CMS |
| UCB, Inc. | $17.10 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143314990 | CMS |
| UCB, Inc. | $21.00 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143314994 | CMS |
| UCB, Inc. | $10.73 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143314999 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.